To kick off the MS Global Healthcare Conference, onSeptember 14, Risinger and Harrison hosted former FDACommissioner Dr. Scott Gottlieb to discuss COVID vaccines, antibodies, and FDA considerations. Dr. Gottlieb is reasonably confident that one or more COVID vaccines will be successful. He believes the Phase 1 and 2 data published thus far has demonstrated relatively robust immunogenicity and also the…
Morgan Stanley Healthcare Conference: Dr. Scott Gottlieb
A financial market resource for the every-day investor and trader.
Related Articles
-
Increased Liquidity Propels S&P 500 In Early 2019
Seth Golden, , Research Reports, 0
The S&P 500 (SPX) and its peer indices have had quite the bullish move off of the Christmas Eve...
-
Macro-Market 2024 Home Stretch
Seth Golden, , Research Reports, 0
Good weekend all! Please take some time to review the thoughts and ideas concerning the macro-market landscape since the...
-
-
-
From Bull To Bear And Back Again
Seth Golden, , Research Reports, 0
During the holiday shortened trading week, the excitement was already anticipated and proclaimed by the bulls with strong market...
-
Wall Street Looks Toward Trump 2.0 And Economic Data Ahead
Seth Golden, , Research Reports, 0
Capital Economics We have revised some of our key market forecasts in response to Donald Trump’s victory and the news...
-
Busting The Myths of Stocks For The Long Run: Part 1
Seth Golden, , Research Reports, 0
By Lance Roberts Part I: Buy and Hold Can Be Hazardous To Your Wealth One would think that following...
-
From Good Overbought To Good Oversold?
Seth Golden, , Research Reports, 0
August has proven itself to be a “Wall of Worry” and the point for which the former “good overbought”...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00